title: [Effects of high and low molecular soluble factors of the bone marrow on antibody formation and pain sensitivity in animals].
abstract: In addition to the immunostimulating activity, bone marrow mediators, myelopeptides (MP) show the dose-dependent effect on the development of pain sensitivity in mice. When injected in nanogram amounts, MP induce hyperalgesia and 3-9 fold higher production of antibodies against SREC. When injected in milligram amounts, they exhibit hypoalgesic effect and no influence on antibody production. Immunostimulating effect in MP (mol, mass less than 1 KD, fraction 3) is accompanied with hypoalgesia. Bone marrow factors of mol. masses 40-150 KD (fraction 1) eluted at Sephadex G-25 gel-filtration before MP enhance the pain sensitivity tHreshold and show a potent immunodepressive effect. Thus the bone marrow factors are capable of exhibiting the opposite effects on the immune system in the pain control system that evidences the tight interrelation between these systems.
authors.forename: O G
authors.initials: OG
authors.lastname: Ianovskiĭ
authors.forename: L A
authors.initials: LA
authors.lastname: Zakharova
authors.forename: A M
authors.initials: AM
authors.lastname: Vasilenko
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000917:Antibody Formation; D001853:Bone Marrow / Q000502:physiology*; D002478:Cells, Cultured; D005260:Female; D006824:Hybridization, Genetic; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D009842:Oligopeptides; D010146:Pain / Q000503:physiopathology*; D010147:Pain Measurement; D010455:Peptides / Q000494:pharmacology*; D012684:Sensory Thresholds
chemical_list: D000276:Adjuvants, Immunologic; D000700:Analgesics; D009842:Oligopeptides; D010455:Peptides; C048617:myelopeptides
vernacular_title: Vliianie vysoko- i nizkomolekuliarnykh rastvorimykh faktorov kostnogo mozga na antiteloobrazovanie i bolevuiu chuvstvitel'nost' u zhivotnykh.